Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.
Saved in:
| Title: | Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study. |
|---|---|
| Authors: | Sharman, Jeff P.1 (AUTHOR) jeff.sharman@usoncology.com, Forero-Torres, Andres2 (AUTHOR), Costa, Luciano J.3 (AUTHOR), Flinn, Ian W.4 (AUTHOR), Inhorn, Lowell5 (AUTHOR), Kelly, Kevin6 (AUTHOR), Bessudo, Alberto7 (AUTHOR), Fayad, Luis E.8 (AUTHOR), Kaminski, Mark S.9 (AUTHOR), Evens, Andrew M.10 (AUTHOR), Flowers, Christopher R.11 (AUTHOR), Sahin, Deniz12 (AUTHOR), Mundt, Kirsten E.12 (AUTHOR), Sandmann, Thomas13 (AUTHOR), Fingerle-Rowson, Günter12 (AUTHOR), Vignal, Charlotte12 (AUTHOR), Mobasher, Mehrdad13 (AUTHOR), Zelenetz, Andrew D.14 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Apr2019, Vol. 60 Issue 4, p894-903. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 135800918 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Sharman%2C+Jeff+P%2E%22">Sharman, Jeff P.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> jeff.sharman@usoncology.com</i><br /><searchLink fieldCode="AR" term="%22Forero-Torres%2C+Andres%22">Forero-Torres, Andres</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Costa%2C+Luciano+J%2E%22">Costa, Luciano J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Flinn%2C+Ian+W%2E%22">Flinn, Ian W.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Inhorn%2C+Lowell%22">Inhorn, Lowell</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kelly%2C+Kevin%22">Kelly, Kevin</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bessudo%2C+Alberto%22">Bessudo, Alberto</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fayad%2C+Luis+E%2E%22">Fayad, Luis E.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kaminski%2C+Mark+S%2E%22">Kaminski, Mark S.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Evens%2C+Andrew+M%2E%22">Evens, Andrew M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Flowers%2C+Christopher+R%2E%22">Flowers, Christopher R.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sahin%2C+Deniz%22">Sahin, Deniz</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mundt%2C+Kirsten+E%2E%22">Mundt, Kirsten E.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sandmann%2C+Thomas%22">Sandmann, Thomas</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fingerle-Rowson%2C+Günter%22">Fingerle-Rowson, Günter</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vignal%2C+Charlotte%22">Vignal, Charlotte</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mobasher%2C+Mehrdad%22">Mobasher, Mehrdad</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zelenetz%2C+Andrew+D%2E%22">Zelenetz, Andrew D.</searchLink><relatesTo>14</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Apr2019, Vol. 60 Issue 4, p894-903. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=135800918 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2018.1515940 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 894 Titles: – TitleFull: Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sharman, Jeff P. – PersonEntity: Name: NameFull: Forero-Torres, Andres – PersonEntity: Name: NameFull: Costa, Luciano J. – PersonEntity: Name: NameFull: Flinn, Ian W. – PersonEntity: Name: NameFull: Inhorn, Lowell – PersonEntity: Name: NameFull: Kelly, Kevin – PersonEntity: Name: NameFull: Bessudo, Alberto – PersonEntity: Name: NameFull: Fayad, Luis E. – PersonEntity: Name: NameFull: Kaminski, Mark S. – PersonEntity: Name: NameFull: Evens, Andrew M. – PersonEntity: Name: NameFull: Flowers, Christopher R. – PersonEntity: Name: NameFull: Sahin, Deniz – PersonEntity: Name: NameFull: Mundt, Kirsten E. – PersonEntity: Name: NameFull: Sandmann, Thomas – PersonEntity: Name: NameFull: Fingerle-Rowson, Günter – PersonEntity: Name: NameFull: Vignal, Charlotte – PersonEntity: Name: NameFull: Mobasher, Mehrdad – PersonEntity: Name: NameFull: Zelenetz, Andrew D. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: Apr2019 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 10428194 Numbering: – Type: volume Value: 60 – Type: issue Value: 4 Titles: – TitleFull: Leukemia & Lymphoma Type: main |
| ResultId | 1 |